EW - Edwards Lifesciences Corporation

NYSE - NYSE Delayed price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts22222626
Avg. Estimate0.650.632.552.89
Low estimate0.620.582.432.65
High estimate0.660.672.63.04
Year ago EPS0.630.612.482.55
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts19192828
Avg. Estimate1.5B1.47B5.96B6.55B
Low estimate1.47B1.43B5.83B6.29B
High estimate1.53B1.53B6.08B6.79B
Year ago sales1.37B1.32B5.38B5.96B
Sales growth (year/est)9.30%11.30%10.60%10.00%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS0.640.620.610.61
Actual EPS0.630.610.640.62
Difference-0.01-0.010.030.01
Surprise %-1.60%-1.60%4.90%1.60%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate0.650.632.552.89
7 days ago0.650.632.552.89
30 days ago0.650.632.552.89
60 days ago0.630.632.512.85
90 days ago0.630.632.512.85
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/AN/A12
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesEWIndustrySector(s)S&P 500
Current qtr.3.20%N/AN/AN/A
Next qtr.3.30%N/AN/AN/A
Current year2.80%N/AN/AN/A
Next year13.30%N/AN/AN/A
Next 5 years (per annum)9.76%N/AN/AN/A
Past 5 years (per annum)10.99%N/AN/AN/A